Sculptra Biostimulator (1 amp)

Sculptra (poly-L-lactic acid) injection to stimulate the body's own collagen production for gradual, natural-looking facial volume restoration. Results develop over 4-6 weeks and can last up to 2 years.

Sculptra is a biostimulator based on poly-L-lactic acid (PLLA) — a synthetic, biocompatible, biodegradable polymer that has been used in dissolvable sutures for decades. Unlike hyaluronic acid fillers that provide immediate volume by physically occupying space, Sculptra works by triggering a controlled inflammatory response that stimulates fibroblasts to produce new type I collagen over several weeks. The result is a gradual restoration of facial volume that looks and feels like the patient's own tissue. At SCM Estetic, Sculptra is reconstituted according to manufacturer guidelines and injected into areas of volume loss using a grid-pattern or fanning technique. Common treatment zones include the temples, cheeks, pre-auricular area, and jawline. The practitioner maps out injection points to ensure even collagen stimulation across the treated area. Each session takes approximately 45 minutes including preparation and post-injection massage. The mechanism of action means results are not immediate. Over 4-6 weeks following injection, the PLLA microparticles stimulate a foreign body response that recruits fibroblasts to the injection sites. These fibroblasts lay down new collagen fibres around the PLLA particles, which then gradually biodegrade over 12-18 months. The collagen matrix remains after the PLLA is absorbed, providing structural support that can last up to 2 years from the initial treatment course. Most patients require 2-3 sessions spaced 4-6 weeks apart for optimal results. Post-treatment, patients are instructed to massage the treated areas using the "5-5-5 rule" — 5 minutes of massage, 5 times daily, for 5 days — to ensure even distribution of the product and prevent nodule formation. SCM Estetic's practitioners are experienced with biostimulator protocols, offering both Sculptra and Ellansé as complementary options depending on the patient's timeline and goals.